BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7166176)

  • 1. Pharmacokinetics of levamisole in healthy subjects and cancer patients.
    Luyckx M; Rousseau F; Cazin M; Brunet C; Cazin JC; Haguenoer JM; Devulder B; Lesieur I; Lesieur D; Gosselin P; Adenis L; Cappelaere P; Demaille A
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):247-54. PubMed ID: 7166176
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of levamisole.
    Adams JG
    J Rheumatol Suppl; 1978; 4():137-42. PubMed ID: 282444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of levamisole in sheep.
    Bogan JA; Marriner SE; Galbraith EA
    Res Vet Sci; 1982 Jan; 32(1):124-6. PubMed ID: 7089376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects.
    Luyckx M; Cazin M; Brunet C; Cazin JC; Devulder B; Gosselin P; Adenis L; Cappelaere P; Granier AM; Demaille A
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):467-9. PubMed ID: 6608036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between levamisole and aspirin in man.
    Rumble RH; Brooks PM; Roberts MS
    Br J Clin Pharmacol; 1979 Jun; 7(6):631-3. PubMed ID: 465288
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of coat length on the bioavailability of levamisole applied topically to cattle.
    Forsyth BA
    Aust Vet J; 1984 Jul; 61(7):241-2. PubMed ID: 6497813
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil.
    Gwilt P; Tempero M; Kremer A; Connolly M; Ding C
    Cancer Chemother Pharmacol; 2000; 45(3):247-51. PubMed ID: 10663643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of [3H]levamisole in pigs after oral and intramuscular administration.
    Galtier P; Escoula L; Alvinerie M
    Am J Vet Res; 1983 Apr; 44(4):583-7. PubMed ID: 6869955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of a levamisole metabolite (DL-2-Oxo-3-[2-mercaptoethyl]-5-phenylimidazolidine) on carbon clearance in mice.
    Van Ginckel R; De Brabander M
    J Reticuloendothel Soc; 1979 Feb; 25(2):125-31. PubMed ID: 439095
    [No Abstract]   [Full Text] [Related]  

  • 10. Whole body distribution of 3H levamisole in rats and mice.
    Benard P; Brunet C; Cazin M; Braun JP; Burgat-Sacaze V; Rico AG
    Dev Toxicol Environ Sci; 1980; 8():529-32. PubMed ID: 7308053
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria.
    Shu YZ; Kingston DG; Van Tassell RL; Wilkins TD
    Xenobiotica; 1991 Jun; 21(6):737-50. PubMed ID: 1949905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution and elimination of [3H]levamisole in the rat after oral and intramuscular administration.
    Galtier P; Coche Y; Alvinerie M
    Xenobiotica; 1983 Jul; 13(7):407-13. PubMed ID: 6659543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement.
    Wolford A; McDonald TS; Eng H; Hansel S; Chen Y; Bauman J; Sharma R; Kalgutkar AS
    Drug Metab Dispos; 2012 Jun; 40(6):1067-75. PubMed ID: 22393119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gas-chromatographic determination of levamisole in human plasma-normalization and reliability of the method.
    Rousseau F; Haguenoer JM; Lesieur D; Gamot AP
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):281-8. PubMed ID: 7333328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excretion of levamisole in milk from cows treated with various formulations.
    Simkins KL; Smith JE; Eggert RG
    J Dairy Sci; 1976 Aug; 59(8):1440-3. PubMed ID: 956482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of levamisole in broiler breeder chickens.
    El-Kholy H; Kemppainen B; Ravis W; Hoerr F
    J Vet Pharmacol Ther; 2006 Feb; 29(1):49-53. PubMed ID: 16420302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome.
    Kreeftmeijer-Vegter AR; Dorlo TP; Gruppen MP; de Boer A; de Vries PJ
    Br J Clin Pharmacol; 2015 Aug; 80(2):242-52. PubMed ID: 25677380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of levamisole and kinetics of levamisole and aminorex in urine by means of LC-QTOF-HRMS and LC-QqQ-MS.
    Hess C; Ritke N; Broecker S; Madea B; Musshoff F
    Anal Bioanal Chem; 2013 May; 405(12):4077-88. PubMed ID: 23436169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonspecific binding of levamisole with proteins of the cuticle-hypodermis-muscle system of adult female Ascaridia galli.
    Roy TK; Srivastava VM; Rao VK
    Indian J Exp Biol; 1981 Apr; 19(4):379-85. PubMed ID: 7275194
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer.
    Reid JM; Kovach JS; O'Connell MJ; Bagniewski PG; Moertel CG
    Cancer Chemother Pharmacol; 1998; 41(6):477-84. PubMed ID: 9554592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.